|
Addex Pharmaceuticals (VTX:ADXN) Addex Starts A Second Phase IIb …
ABN Newswire (press release), Australia - Dec 16, 2008 Objective measures of the effects of ADX10059 on lower esophageal sphincter (LES) function and acid reflux events will be made in a subset of patients using … Addex Starts a Second Phase IIb Trial of ADX10059 in GERD International Business Times all 48 news articles |
Source:Addex Pharmaceuticals (VTX:ADXN) Addex Starts A Second Phase IIb … – ABN Newswire (press release)